Apr 24 2025
In a new study published in the journal Expert Review of Neurotherapeutics, “cannabis-based medicinal products were associated with improvements in PTSD symptoms, anxiety, sleep, and health-related quality of life” over an 18-month period. The study followed 269 PTSD patients who were prescribed cannabis-based medicinal products (CBMPs) for at least 18 months. Conducted by researchers from …
Apr 24 2025
According to a study conducted by researchers from eight universities, cannabinoids may be effective in managing core symptoms of Tourette Syndrome. A new systematic review and meta-analysis has found that cannabis-based medications may significantly reduce the severity of tics and premonitory urges in individuals with Tourette Syndrome. The study was conducted by researchers from eight …
Apr 24 2025
A study conducted at Namseoul University in South Korea has found that tetrahydrocannabivarin (THCV), a non-psychoactive cannabinoid found in marijuana, could offer therapeutic benefits for those with metabolic disorders such as obesity and type 2 diabetes. Published by AIMS Neuroscience, the study highlights THCV’s unique interaction with the body’s endocannabinoid system, including its ability to …
Apr 24 2025
A new study published in the Asian Journal of Urology has found that certain cannabis strains rich in cannabinoids like CBC and THC may be effective in killing bladder cancer cells and inhibiting their spread. Researchers from Bar Ilan University, Tel Aviv University, and the Cleveland Clinic tested three commercial Cannabis sativa strains—PARIS, Dairy Queen …
Apr 23 2025
A study from Clemson University has found that adding far-red light to red-blue light treatments significantly boosts shoot production and growth in marijuana plants grown in vitro. Researchers studied two hemp varieties—’BaOx’ and ‘Cherry 1’—in controlled growth vessels under varying red-to-blue light ratios, with and without the addition of 5% far-red light. Plants were harvested …
Apr 22 2025
A new study published in the journal Indian Pediatrics finds that cannabidiol (CBD) can be an effective and well-tolerated treatment for children with drug-resistant epilepsy (DRE), including those with Lennox-Gastaut and Dravet syndromes. Researchers from the Indira Gandhi Institute of Child Health reviewed the medical records of 50 children with DRE who had been treated …
Apr 22 2025
New research presented at the 2025 European Congress of Psychiatry reveals that the use of cannabidiol (CBD)-heavy cannabis extract can lead to meaningful benefits and improve the behavior of children and adolescents with autism spectrum disorder (ASD). ASD affects approximately 1 in 100 children around the world and symptoms can include difficult language, difficulty expressing …
Apr 22 2025
According to a new study from Mayo Clinic researchers, psilocybin therapy may help ease psychological suffering in cancer patients. A new systematic review published in the journal Palliative & Supportive Care finds that psilocybin-assisted therapy may significantly reduce symptoms of psychological and existential distress in people with life-threatening cancer. The review was conducted by researchers …
Apr 18 2025
A randomized, double-blind clinical trial conducted at Buriram Hospital in Thailand found that daily sublingual cannabidiol (CBD) was safe for individuals with Parkinson’s disease and led to improvements in naming ability, an important aspect of cognitive function. The trial included 60 Parkinson’s disease patients, evenly split between those receiving a CBD-enriched product and those given …
Apr 18 2025
A new study finds that hemp crude oil may offer an effective alternative to antibiotics for combating a harmful bacterium commonly found in grain-finished beef cattle. Researchers from the USDA Agricultural Research Service, the University of Kentucky, and Kansas State University have published findings in the journal Anaerobe showing that Cannabis sativa L. (hemp) crude …
